263 related articles for article (PubMed ID: 38617845)
1. Precision Medicine in the Era of Genetic Testing: Microsatellite Instability Evolved.
Ioffe D; McSweeny M; Hall MJ
Clin Colon Rectal Surg; 2024 May; 37(3):157-171. PubMed ID: 38617845
[TBL] [Abstract][Full Text] [Related]
2. Immune Checkpoint Blockade Therapy in Patients With Colorectal Cancer Harboring Microsatellite Instability/Mismatch Repair Deficiency in 2022.
André T; Cohen R; Salem ME
Am Soc Clin Oncol Educ Book; 2022 Apr; 42():1-9. PubMed ID: 35471834
[TBL] [Abstract][Full Text] [Related]
3. Current Microsatellite Instability Testing in Management of Colorectal Cancer.
Sun BL
Clin Colorectal Cancer; 2021 Mar; 20(1):e12-e20. PubMed ID: 32888812
[TBL] [Abstract][Full Text] [Related]
4. [Novel Treatment Concepts in Patients with Colorectal Carcinomas and High Microsatellite Instability].
Vangala D; Nilius-Eliliwi V
Zentralbl Chir; 2023 Dec; 148(6):475-482. PubMed ID: 36848937
[TBL] [Abstract][Full Text] [Related]
5. Complete Pathological Response After Neoadjuvant Short-Course Immunotherapy with Ipilimumab and Nivolumab in Locally Advanced MSI-H/dMMR Rectal Cancer.
Trojan J; Stintzing S; Haase O; Koch C; Ziegler P; Demes M; Jelas I
Oncologist; 2021 Dec; 26(12):e2110-e2114. PubMed ID: 34431576
[TBL] [Abstract][Full Text] [Related]
6. An updated review of microsatellite instability in the era of next-generation sequencing and precision medicine.
Yamamoto H; Imai K
Semin Oncol; 2019 Jun; 46(3):261-270. PubMed ID: 31537299
[TBL] [Abstract][Full Text] [Related]
7. The distinct clinical trajectory, metastatic sites, and immunobiology of microsatellite-instability-high cancers.
Han S; Chok AY; Peh DYY; Ho JZ; Tan EKW; Koo SL; Tan IB; Ong JC
Front Genet; 2022; 13():933475. PubMed ID: 36531239
[TBL] [Abstract][Full Text] [Related]
8. [Diagnosis and Treatment of MSI-H Cancer in Gynecological Cancer].
Yamamoto N; Tashiro H; Katabuchi H
Gan To Kagaku Ryoho; 2018 Nov; 45(11):1577-1581. PubMed ID: 30449841
[TBL] [Abstract][Full Text] [Related]
9. Microsatellite instability is biased in Amsterdam II-defined Lynch-related cancer cases with family history but is rare in other cancers: a summary of 1000 analyses.
Matsubayashi H; Higashigawa S; Kiyozumi Y; Oishi T; Sasaki K; Ishiwatari H; Imai K; Hotta K; Yabuuchi Y; Ishikawa K; Satoh T; Ono H; Todaka A; Kawakami T; Shirasu H; Yasui H; Sugiura T; Uesaka K; Kagawa H; Shiomi A; Kado N; Hirashima Y; Kiyohara Y; Bando E; Niwakawa M; Nishimura S; Aramaki T; Mamesaya N; Kenmotsu H; Horiuchi Y; Serizawa M
BMC Cancer; 2022 Jan; 22(1):73. PubMed ID: 35039004
[TBL] [Abstract][Full Text] [Related]
10. Microsatellite instability in noncolorectal and nonendometrial malignancies in patients with Lynch syndrome.
Elze L; van der Post RS; Vos JR; Mensenkamp AR; de Hullu MSC; Nagtegaal ID; Hoogerbrugge N; de Voer RM; Ligtenberg MJL
J Natl Cancer Inst; 2023 Jul; 115(7):853-860. PubMed ID: 37018159
[TBL] [Abstract][Full Text] [Related]
11. Lynch Syndrome and MSI-H Cancers: From Mechanisms to "Off-The-Shelf" Cancer Vaccines.
Roudko V; Cimen Bozkus C; Greenbaum B; Lucas A; Samstein R; Bhardwaj N
Front Immunol; 2021; 12():757804. PubMed ID: 34630437
[TBL] [Abstract][Full Text] [Related]
12. Mismatch repair deficiency, next-generation sequencing-based microsatellite instability, and tumor mutational burden as predictive biomarkers for immune checkpoint inhibitor effectiveness in frontline treatment of advanced stage endometrial cancer.
Hill BL; Graf RP; Shah K; Danziger N; Lin DI; Quintanilha J; Li G; Haberberger J; Ross JS; Santin AD; Slomovitz B; Elvin JA; Eskander RN
Int J Gynecol Cancer; 2023 Apr; 33(4):504-513. PubMed ID: 36750267
[TBL] [Abstract][Full Text] [Related]
13. A gene expression assay for simultaneous measurement of microsatellite instability and anti-tumor immune activity.
Danaher P; Warren S; Ong S; Elliott N; Cesano A; Ferree S
J Immunother Cancer; 2019 Jan; 7(1):15. PubMed ID: 30665466
[TBL] [Abstract][Full Text] [Related]
14. Is There a Role for Programmed Death Ligand-1 Testing and Immunotherapy in Colorectal Cancer With Microsatellite Instability? Part I-Colorectal Cancer: Microsatellite Instability, Testing, and Clinical Implications.
Marginean EC; Melosky B
Arch Pathol Lab Med; 2018 Jan; 142(1):17-25. PubMed ID: 29144791
[TBL] [Abstract][Full Text] [Related]
15. Tumor-agnostic drug development in dMMR/MSI-H solid tumors.
Bhamidipati D; Subbiah V
Trends Cancer; 2023 Oct; 9(10):828-839. PubMed ID: 37517955
[TBL] [Abstract][Full Text] [Related]
16. A phase 2 evaluation of pembrolizumab for recurrent Lynch-like versus sporadic endometrial cancers with microsatellite instability.
Bellone S; Roque DM; Siegel ER; Buza N; Hui P; Bonazzoli E; Guglielmi A; Zammataro L; Nagarkatti N; Zaidi S; Lee J; Silasi DA; Huang GS; Andikyan V; Damast S; Clark M; Azodi M; Schwartz PE; Tymon-Rosario JR; Harold JA; Mauricio D; Zeybek B; Menderes G; Altwerger G; Ratner E; Alexandrov LB; Iwasaki A; Kong Y; Song E; Dong W; Elvin JA; Choi J; Santin AD
Cancer; 2022 Mar; 128(6):1206-1218. PubMed ID: 34875107
[TBL] [Abstract][Full Text] [Related]
17. Immune Microenvironment in Microsatellite-Instable Endometrial Cancers: Hereditary or Sporadic Origin Matters.
Pakish JB; Zhang Q; Chen Z; Liang H; Chisholm GB; Yuan Y; Mok SC; Broaddus RR; Lu KH; Yates MS
Clin Cancer Res; 2017 Aug; 23(15):4473-4481. PubMed ID: 28264871
[No Abstract] [Full Text] [Related]
18. How I treat MSI cancers with advanced disease.
Kok M; Chalabi M; Haanen J
ESMO Open; 2019; 4(Suppl 2):e000511. PubMed ID: 31231574
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant Immune Checkpoint Inhibitor Therapy for Patients With Microsatellite Instability-High Colorectal Cancer: Shedding Light on the Future.
Sahin IH; Zhang J; Saridogan T; Gorantla V; Rhree J; Malhotra M; Thomas R; Hsu D; Saeed A
JCO Oncol Pract; 2023 May; 19(5):251-259. PubMed ID: 36862965
[TBL] [Abstract][Full Text] [Related]
20. Immune checkpoint inhibition in advanced colorectal cancer with inherited and acquired microsatellite instability: Current state and future directions.
Dasanu CA; Alani M; Habibi S; Codreanu I
J Oncol Pharm Pract; 2023 May; ():10781552231178293. PubMed ID: 37246506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
